Company / R&D per Share
Pacira BioSciences, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.54
FY2025
5-year range
$1.65 / $2.54
FY2021-FY2025
Trend
+43.8%
vs FY2024
Sector context
#83 of 208
Health Care
What the data says
At $2.54, Pacira BioSciences, Inc.'s r&d per share ranks #83 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.76 in FY2017 to $2.54 in FY2025.
Based on SEC 10-K filings.
2.54 in FY2025 with a 5-year CAGR of +13.8%.
Improved from $1.66 to $2.54 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +10.2%
- 5-Year CAGR
- +13.8%
- 10-Year CAGR
- -
Sector benchmark
#83 of 208 in Health CareTop 40% of 208This company $2.54 Sector average $12.19
▼
-79.2% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 43.8% year-over-year.
- Ranks #83 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2017.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.54 | +43.8% |
| FY2024 | $1.76 | +6.2% |
| FY2023 | $1.66 | -12.4% |
| FY2022 | $1.90 | +14.7% |
| FY2021 | $1.65 | +24.4% |
| FY2020 | $1.33 | -4.4% |
| FY2019 | $1.39 | +23.7% |
| FY2018 | $1.12 | +46.9% |
| FY2017 | $0.76 | -38.3% |
| FY2016 | $1.24 | +56.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026